Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi Twelve countries across different regions in Africa are set to receive 18 million doses of the first-ever malaria vaccine over the next two years. The roll out is a critical step forward in the fight against one of the leading causes […]
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi The World Health Organization (WHO) on Thursday launched its mRNA vaccine technology hub in South Africa’s Cape Town, to help poorer countries struggling to gain access to life-saving medication. www.reuters.com/business/healthcare-pharmaceuticals/who-officially-launches-mrna-vaccine-hub-cape-town-2023-04-20/ In 2021, the WHO picked South African biotech firm Afrigen Biologics
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi President Joe Biden’s administration said this week it plans to spend more than $5 billion to stoke development of better coronavirus vaccines and treatments to curb future pandemics. www.science.org/content/article/news-glance-new-us-coronavirus-research-lab-gears-carbon-cost-repurposed-accelerator? Like Operation Warp Speed, its predecessor during the administration of former President
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi Advisers to the US Centers for Disease Control and Prevention (CDC) has voted in favour of the Bavarian Nordic’s Jynneos vaccine for all adults at risk of mpox during an outbreak. https://www.medscape.com/viewarticle/988606?src=wnl_edit_tpal&uac=398271FG&impID=5194437&faf=1 The panel of outside experts voted unanimously in favour
CDC votes in favour of mpox vaccine; The latest health stories from around the world Read More »
A team of researchers affiliated with several entities in Thailand, working with two colleagues from the US and two from Canada, has developed an mRNA COVID-19 vaccine that can be safely refrigerated for up to three months before use. The team has named it ChulaCov19. In their paper published in the journal Nature Microbiology, the
Research in Thailand develops long shelf life COVID-19 vaccine Read More »
A new vaccine against malaria has shown promising preliminary results in a large trial in four African countries, boosting hopes that an additional tool may soon be available to help control the deadly disease. www.science.org/content/article/new-data-buoys-hopes-promising-malaria-vaccine-questions-remain The vaccine, named R21/Matrix-M and developed by researchers at the University of Oxford, produced similarly impressive results in a small trial last
Vaccine trial against malaria shows promising results Read More »
The Chinese city of Shanghai started administering an inhalable COVID-19 vaccine last Wednesday in what appears to be a world first. www.pbs.org/newshour/world/china-begins-administering-inhalable-covid-19-vaccine-boosters? The vaccine, a mist that is sucked in through the mouth, is being offered for free as a booster dose for previously vaccinated people, according to an announcement on an official city social
Shanghai rolls out inhalable COVID-19 vaccine Read More »
A new generation of COVID-19 vaccines that can be inhaled or sprayed up the nose—instead of taken by injection—will begin rolling out in Asia, though just how effective they are remains to be seen. Regulators in China and India have greenlighted distribution of vaccines delivered through the mouth or nose, a delivery that scientists say
A new generation of inhaled COVID vaccines Read More »
Subscribe our newsletter to stay updated
Copyright © 2023 | Health Issues Africa | All rights reserved.
